Pfizer Ends Development of Cholesterol Drug

from National Public Radio
December 4, 2006

Pfizer has announced it is ending development of a much-anticipated cholesterol-reducing drug for heart patients. The company says an independent board has found increased deaths and heart problems among patients in a late-stage trial of torcetrapib.

Broadcast Dates

Latest News & Features


News Cut

with Bob Collins